Skip to main content
. 2021 Oct 15;11:745719. doi: 10.3389/fonc.2021.745719

Figure 9.

Figure 9

Validation of the association between m6A regulators and tumor microenvironment in a clinical cohort. (A) Expression of m6A regulators in high-risk group and low-risk group. (B) Expression of the 6 m6A-related lncRNAs in our clinical validation cohort. (C) The expression levels of METTL3 were significantly increased and METTL14 were significantly decreased in the high-risk patients than those in the low-risk patients of the clinical validation cohort. (D) Abundant M2 macrophage infiltration and co-expression of M2 macrophage marker CD206 and METTL14 was found in high-risk patients of the clinical validation cohort. *P < 0.05, **P < 0.01, ***P < 0.001. ns, no significance.